Weight Loss
Tirzepatide
5mg / vial
A synthetic dual GIP/GLP-1 receptor agonist investigated for effects on glucose metabolism, insulin secretion, and appetite regulation. Research examines HbA1c reduction, substantial weight loss outcomes, liver fat content changes, and cardiometabolic parameters including blood pressure and lipid profiles in obesity and type 2 diabetes models.
$129.99
Size
≥98% Purity
Third-party verified
Cold-Chain Shipping
Free on every order
COA Included
HPLC · LC-MS · NMR
Same-Day Shipping
Orders before 1PM EST
For Research Use Only. Not for human or animal consumption. Not a drug, food, or cosmetic. For in vitro laboratory research by qualified researchers only.
Areas of Investigation
Research Applications
Dual Action
Dual Incretin Signaling
Studied as the first dual GIP/GLP-1 receptor agonist, activating both incretin pathways for synergistic metabolic effects.
Weight Loss
Body Weight Reduction
Demonstrated significant weight loss in large-scale clinical trials, with some participants achieving over 20% body weight reduction.
Blood Sugar
Glucose & Insulin Research
Evaluated for robust glucose-lowering effects and improvements in insulin sensitivity through dual receptor activation.
Liver Health
Liver & Lipid Research
Under investigation for effects on non-alcoholic steatohepatitis (NASH) and improvements in lipid profiles.
Technical Data
Compound Profile
Full compound characterization including molecular structure, physical properties, storage requirements, and stability data for research use.
≥98% Purity Guaranteed
HPLC · LC-MS · Third-Party Verified
Molecular Formula
C₂₂₅H₃₄₈N₄₈O₆₈
Molecular Weight
4,813.45 g/mol
Appearance
White lyophilized powder
Storage (Lyophilized)
Below −20°C, desiccated, away from light and moisture
Storage (Reconstituted)
Refrigerate at 2–8°C; use within 28 days. Protect from light.
Shelf Life
24 months from manufacture date
Third-Party Verified
Certificate of Analysis
99.76%
PURITY
Tirzepatide · Batch A
TAP TO VIEW FULL COA
Batch Analysis Report
Lot Number
PLQ-TIRZ-2601-A
Labeled Amount
5mg
Actual Amount
5.42mg
Testing Date
01/20/2026
Tested By
Apex Analytics Lab (Third-Party)
Methods
HPLC · LC-MS · NMR · FTIR
Full COA documentation is included with every order. COAs are batch-specific and reflect the exact lot shipped. Independent third-party verification ensures unbiased purity and identity confirmation.
Protocol
Storage & Handling
Long-Term Storage
Store lyophilized peptide at −20°C. Under these conditions the product remains stable for up to 24 months from the date of manufacture.
After Reconstitution
Once reconstituted, store at 4°C and use within 30 days. Avoid repeated freeze-thaw cycles as this may degrade compound integrity.
Shipping Conditions
All orders ship in insulated packaging with cooling packs to maintain the cold chain during transit. Free on every order, no minimum required.
Support
Frequently Asked Questions
Tirzepatide activates both GIP and GLP-1 receptors simultaneously — the first dual incretin receptor agonist. Semaglutide is selective for GLP-1 only. The addition of GIP receptor activity is studied for additive insulin secretion, enhanced adipose tissue effects, and greater body weight reduction outcomes compared to GLP-1 agonism alone.
The C-20 fatty diacid moiety enables reversible albumin binding that extends tirzepatide's half-life to approximately 5 days, supporting once-weekly dosing in research protocols and sustained dual-receptor activation for longer-duration metabolic studies.
This is research-grade tirzepatide — the same molecule studied in clinical trials but not equivalent to FDA-approved pharmaceutical formulations. It is strictly for in vitro laboratory research by qualified researchers. Not for human or animal consumption.
Add bacteriostatic water slowly along the vial wall, gently swirl until dissolved, and do not shake. Store reconstituted solution at 2–8°C, protected from light, and use within 28 days.
Our tirzepatide is verified at ≥98% purity via third-party HPLC analysis. The current batch is confirmed at 99.76% by Apex Analytics Lab. A full COA ships with every order.
Explore More
Related Products
Weight Loss
Semaglutide
A long-acting GLP-1 receptor agonist studied extensively in preclinical research for glucose control through pancreatic beta-cell activation and insulin secretion, appetite and weight reduction via CNS pathways, and cardiometabolic effects including blood pressure and lipid profile modulation.
$119.99
Weight Loss
Retatrutide
A synthetic triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways. Researched for body-weight reduction, glucose regulation, and energy expenditure in obesity models. Combined GLP-1/GIP signaling is examined for glycemic control, while glucagon receptor activation is studied for hepatic glucose output and lipid metabolism effects.
$99.99